Scarica l'app Stockscreener
5.415
1.12%
0.055
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.36
Aprire:
$5.47
Volume 24 ore:
807.98K
Relative Volume:
1.00
Capitalizzazione di mercato:
$277.67M
Reddito:
-
Utile/perdita netta:
$-54.19M
Rapporto P/E:
-2.0988
EPS:
-2.58
Flusso di cassa netto:
$-37.34M
1 W Prestazione:
+1.50%
1M Prestazione:
-15.71%
6M Prestazione:
+17.83%
1 anno Prestazione:
-15.44%
Intervallo 1D:
$5.211
$5.51
Intervallo di 1 settimana:
$5.211
$5.73
Portata 52W:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Nome
Abeona Therapeutics Inc
Settore
Industria
Telefono
646-813-4701
Indirizzo
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Confronta ABEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.415 | 274.85M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-03-05 | Iniziato | Oppenheimer | Outperform |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-30 | Iniziato | Stifel | Buy |
| 2020-11-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-02-10 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Downgrade | Maxim Group | Buy → Hold |
| 2019-08-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Downgrade | Mizuho | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2018-10-12 | Iniziato | Mizuho | Buy |
| 2018-06-05 | Iniziato | Seaport Global Securities | Buy |
| 2017-11-08 | Iniziato | SunTrust | Buy |
| 2017-10-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Iniziato | Citigroup | Buy |
| 2017-10-05 | Reiterato | Maxim Group | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-18 | Reiterato | Maxim Group | Buy |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2017-01-06 | Iniziato | Jefferies | Buy |
| 2016-09-29 | Reiterato | Maxim Group | Buy |
Mostra tutto
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Abeona Therapeutics Inc. stock daily chart insightsJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
Is Abeona Therapeutics Inc. stock oversold or undervaluedWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
Abeona Therapeutics Inc. stock trend forecastJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Abeona Therapeutics (ABEO) Joins FDA's RDEA Pilot Program for Ge - GuruFocus
Abeona’s gene therapy for rare eye disease selected for FDA pilot program - Investing.com Nigeria
H.C. Wainwright reaffirms Buy rating on Abeona Therapeutics stock at $20 - Investing.com UK
ABEO Stock: HC Wainwright Reiterates Buy Rating Maintaining $20 Price Target | ABEO Stock News - GuruFocus
Abeona Therapeutics® Announces ABO-503 Gene Therapy for - GlobeNewswire
Why Abeona Therapeutics Inc. is moving todayDollar Strength & Real-Time Buy Signal Alerts - newser.com
3 Top Growth Stocks Insiders Are Eager To Hold - Yahoo Finance
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Is Abeona Therapeutics Inc. (PCJ) stock a top dividend aristocrat candidate2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Will Abeona Therapeutics Inc. (PCJ) stock benefit from Fed rate cutsMarket Sentiment Summary & Verified Technical Trade Signals - newser.com
Is Abeona Therapeutics Inc a good long term investmentWeekly Market Snapshot & Small Entry Portfolio - earlytimes.in
Is Abeona Therapeutics Inc. (PCJ) stock a good hedge against inflationTake Profit & Growth Oriented Trade Recommendations - newser.com
What drives Abeona Therapeutics Inc stock priceMoving Average Crossovers & Free High Margin Investment Plays - earlytimes.in
Abeona Therapeutics' (ABEO) "Hold (C-)" Rating Reiterated at Weiss Ratings - MarketBeat
Abeona Therapeutics (ABEO) Expands Treatment Options for RDEB Pa - GuruFocus
Abeona Therapeutics and Children's Hospital Colorado Activate New Center for ZEVASKYN Treatment of Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy - The Manila Times
Abeona Therapeutics® and Children's Hospital Colorado - GlobeNewswire
Children's Hospital Colorado named newest QTC for Abeona's FDA‑approved ZEVASKYN to treat RDEB - Stock Titan
What analysts say about Abeona Therapeutics Inc PCJ stockPrice Volatility Patterns & Outstanding Return Stocks - earlytimes.in
What drives Abeona Therapeutics Inc PCJ stock priceDividend Cut Warnings & Low Cost Capital Trading - earlytimes.in
Will Abeona's Gene Therapy For Dystrophic Epidermolysis Bullosa Achieve Wider Adoption? - RTTNews
Abeona Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Small Budget Capital Investment - earlytimes.in
Analyzing drawdowns of Abeona Therapeutics Inc. with statistical tools2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Market reaction to Abeona Therapeutics Inc.’s recent newsQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
What’s next for Abeona Therapeutics Inc. stock priceJuly 2025 Fed Impact & Daily Stock Trend Reports - newser.com
Analyzing recovery setups for Abeona Therapeutics Inc. investorsQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Understanding Abeona Therapeutics Inc.’s price movementIPO Watch & Short-Term Swing Trade Alerts - newser.com
Why Abeona Therapeutics Inc. (PCJ) stock attracts HNW investorsJuly 2025 Retail & Technical Pattern Alert System - newser.com
Can Abeona Therapeutics Inc. stock sustain free cash flow growthMarket Risk Analysis & Short-Term Trading Alerts - newser.com
Order flow analysis tools used on Abeona Therapeutics Inc.July 2025 Trade Ideas & Community Verified Trade Alerts - newser.com
Will Abeona Therapeutics Inc. stock maintain momentum in 2025Trade Analysis Summary & Weekly Market Pulse Updates - newser.com
Abeona Therapeutics Inc Azioni (ABEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Abeona Therapeutics Inc Azioni (ABEO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Seshadri Vishwas | Chief Executive Officer |
Sep 30 '25 |
Sale |
5.24 |
25,000 |
130,930 |
1,190,067 |
| Seshadri Vishwas | Chief Executive Officer |
Sep 29 '25 |
Sale |
5.39 |
19,274 |
103,954 |
1,215,067 |
| Vazzano Joseph Walter | Chief Financial Officer |
Sep 29 '25 |
Sale |
5.39 |
9,035 |
48,730 |
453,631 |
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):